Logo1 logo2
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Fredun Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:539730NSE Symbol: Not ListedP/E(TTM):44.65
ISIN Demat:INE194R01017Div & Yield %:0.03EPS(TTM):60.24
Book Value(Rs):489.430006Market Cap (rupee Cr.):1482.67Face Value(Rs):10
    Change Company 
Date Headline
09-Jun-26 Fredun Pharmaceuticals to convene AGM
29-May-26 Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter
25-May-26 Board of Fredun Pharmaceuticals approves bonus issue of 2:1
25-May-26 Board of Fredun Pharmaceuticals recommends final dividend
25-May-26 Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter
16-May-26 Fredun Pharmaceuticals to announce Quarterly Result
29-Apr-26 Fredun Pharmaceuticals sets up its 5th manufacturing unit in Palghar
09-Apr-26 Fredun Pharmaceuticals allots 40,000 equity shares on conversion of warrants
13-Feb-26 Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter
31-Jan-26 Fredun Pharmaceuticals to convene board meeting
<< < 1 2 3 > >>